PhotoSense, Beckman Laser Collaborate on Medical Photonics
BOULDER, Colo., July 6 -- PhotoSense LLC and the Beckman Laser Institute at the University of California - Irvine have signed an agreement to commercialize non-invasive medical photonic technologies. The Beckman Laser Institute has developed and patented technologies for non-invasive measurement of blood, tissue and muscle properties.
The photonic technology, developed by Dr. Bruce Tromberg, associate professor, and Dr. Michael Berns, institute director, measures the properties of low-level laser light passing through tissue and blood. These optical measurements can be correlated to important physiological conditions to enable the detection of cancer (via optical biopsy), analysis of hematology and blood gas, monitoring of hormonal cycles, and evaluation of burn wounds and other tissue damage. Unlike existing optical medical sensors, the Institute's technology, known as Frequency Domain Photon Migration, measures and compensates for tissue's high levels of scattering and absorption.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024